Soleno Therapeutics (SLNO) “announced that the FDA has approved VYKAT XR, diazoxide choline, extended-release tablets, previously referred to ...
Soleno Therapeutics (SLNO) “announced that the FDA has approved VYKAT XR, diazoxide choline, extended-release tablets, previously referred to ...
Among patients with diabetes receiving PCI, novel antidiabetic agents may reduce risk for acute kidney injury.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback